icon-folder.gif   Conference Reports for NATAP  
 
  15th European AIDS Conference (EACS)
October 21-24, 2015
Barcelona
Back grey_arrow_rt.gif
 
 
 
TAF in Women/WAVES Global Women's Study - The Efficacy and Safety of Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve Women With HIV-1 Infection: Week 48 Analysis of the Phase 3, Randomized, Double-blind Study
 
 
  Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain - 15th European AIDS Conference
 
Cissy Kityo,1 Kathleen Squires,2 Margaret Johnson,3 Teresa Branco,4 Frank Post,5 Oleg Kozyrev,6 Debbie Hagins,7 Anchalee Avihingsanon,8 Shuping Jiang,9 Kirsten White,9 Andrew Cheng,9 Javier Szwarcberg,9 Huyen Cao,9 WAVES Study Group
 
1Joint Clinical Research Centre, Kampala, Uganda; 2Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA; 3Royal Free Hospital, London, UK; 4Hospital Prof Doutor Fernando Fonseca, EPE, Amadora, Portugal; 5Kings College London, UK; 6Volgograd Center of AIDS, Volgograd, Russian Federation; 7Chatham County Health Department, Savannah, Georgia, USA; 8The Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 9Gilead Sciences, Inc., Foster City, California, USA

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif